These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
151 related articles for article (PubMed ID: 19728759)
1. Immunophenotyping parameters as prognostic factors in T-acute leukemia patients. Babusikova O; Stevulova L; Fajtova M Neoplasma; 2009; 56(6):508-13. PubMed ID: 19728759 [TBL] [Abstract][Full Text] [Related]
2. [Bone marrow immunophenotypes of 112 cases of lymphoid system malignant diseases]. Ling JY; Sun XF; Yan SL; He LR; Zhen ZJ; Xia Y Ai Zheng; 2007 Apr; 26(4):418-22. PubMed ID: 17430665 [TBL] [Abstract][Full Text] [Related]
4. [Immunologic characteristics and prognosis of acute myeloid leukemia M1]. Zhao F; Chen Y Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2007 Aug; 15(4):687-91. PubMed ID: 17708783 [TBL] [Abstract][Full Text] [Related]
5. Increased myeloid precursors in regenerating bone marrow; implications for detection of minimal residual disease in acute myeloid leukemia. Zeleznikova T; Stevulova L; Kovarikova A; Babusikova O Neoplasma; 2007; 54(6):471-7. PubMed ID: 17949229 [TBL] [Abstract][Full Text] [Related]
6. CD2 and CD7 are sensitive flow cytometry screening markers for T-lineage acute leukemia(s): a study of 465 acute leukemia cases. Rozenova KA; Jevremovic D; Reichard KK; Nguyen P; Otteson GE; Timm MM; Horna P; Olteanu H; Shi M Hum Pathol; 2021 Aug; 114():66-73. PubMed ID: 34019867 [TBL] [Abstract][Full Text] [Related]
7. [Minimal residual disease monitoring by flow cytometry in children with acute lymphoblastic leukemia]. Popov AM; Verzhbitskaia TIu; Tsaur GA; Shorikov EV; Savel'ev LI; Tsvirenko SV; Fechina LG Klin Lab Diagn; 2010 Aug; (8):36-41. PubMed ID: 20886718 [TBL] [Abstract][Full Text] [Related]
9. Flow cytometric analysis of acute leukemias. Diagnostic utility and critical analysis of data. Kaleem Z; Crawford E; Pathan MH; Jasper L; Covinsky MA; Johnson LR; White G Arch Pathol Lab Med; 2003 Jan; 127(1):42-8. PubMed ID: 12521365 [TBL] [Abstract][Full Text] [Related]
10. Leukemia-associated marker combinations in acute leukemia suitable for detection of minimal residual disease. Babusíková O; Mesárosová A; Koníková M; Kusenda J; Glasová M; Klobusická M Neoplasma; 1993; 40(5):275-81. PubMed ID: 8272155 [TBL] [Abstract][Full Text] [Related]
11. No prognostic significance of immunophenotypic changes at the end of remission induction therapy in children with B-lineage acute lymphoblastic leukemia. Dai Q; Liu X; Yang H; Guo S; Wang Y; Peng L; Ye L; Chen L; Lai C; Chen Q; Zhang G; Jiang Y Leuk Res; 2018 May; 68():57-61. PubMed ID: 29544133 [TBL] [Abstract][Full Text] [Related]
12. The analogy in cell immunophenotype and parameters of cell cycle of ectopic thymus, normal thymus, and some acute lymphoblastic leukemia of T-phenotype. Babusíková O; Tomová A Neoplasma; 2002; 49(5):312-8. PubMed ID: 12458329 [TBL] [Abstract][Full Text] [Related]
13. Prognostic value of immunophenotyping in acute myeloid leukemia. Australian Leukaemia Study Group. Bradstock K; Matthews J; Benson E; Page F; Bishop J Blood; 1994 Aug; 84(4):1220-5. PubMed ID: 8049437 [TBL] [Abstract][Full Text] [Related]
14. [Immunophenotype characteristics and prognosis of acute leukemia patients with cross expressing lymphoid and myeloid lineage associated antigens]. Jiang NG; Chen XM; Zhu HL; Zhong L; Zeng TT; Jia YQ Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2010 Dec; 18(6):1405-9. PubMed ID: 21176339 [TBL] [Abstract][Full Text] [Related]
15. [Characteristics and monitoring of minimal residual disease in patients with T acute lymphoid leukemia by flow cytometry with two 4-color combinations of fluorescent antibodies]. Li L; Yuan XJ; Xu C; Jiang LM; Shen LS Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2012 Oct; 20(5):1103-9. PubMed ID: 23114128 [TBL] [Abstract][Full Text] [Related]
16. Immaturity associated antigens are lost during induction for T cell lymphoblastic leukemia: implications for minimal residual disease detection. Roshal M; Fromm JR; Winter S; Dunsmore K; Wood BL Cytometry B Clin Cytom; 2010 May; 78(3):139-46. PubMed ID: 20155852 [TBL] [Abstract][Full Text] [Related]
17. [Immunophenotyping characteristics of T-cell acute lymphoblastic leukemia]. Chen LJ; Li JY; Wu YJ; Yang H; Qian SX; Wu HX; Lu H; Xu W; Sheng RL Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2007 Aug; 15(4):692-5. PubMed ID: 17708784 [TBL] [Abstract][Full Text] [Related]
18. Prognostic value of cell marker analysis in de novo acute myeloid leukemia. Del Poeta G; Stasi R; Venditti A; Suppo G; Aronica G; Bruno A; Masi M; Tabilio A; Papa G Leukemia; 1994 Mar; 8(3):388-94. PubMed ID: 7907393 [TBL] [Abstract][Full Text] [Related]
19. Acute myeloid leukemia with MLL rearrangements: clinicobiological features, prognostic impact and value of flow cytometry in the detection of residual leukemic cells. Muñoz L; Nomdedéu JF; Villamor N; Guardia R; Colomer D; Ribera JM; Torres JP; Berlanga JJ; Fernández C; Llorente A; Queipo de Llano MP; Sánchez JM; Brunet S; Sierra J; Leukemia; 2003 Jan; 17(1):76-82. PubMed ID: 12529663 [TBL] [Abstract][Full Text] [Related]
20. The immunophenotype of adult T acute lymphoblastic leukemia in Morocco. Lahjouji A; Bachir F; Bennani S; Quessar A; Amzazi S Exp Oncol; 2015 Mar; 37(1):64-9. PubMed ID: 25804235 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]